Evidence level: C
上一篇用恒等式证明「年龄常模 z 化不改 SEM」,那个证明其实只借了一条前提:测量误差的方差与年龄无关。这条前提从未被检验过,而检验它的那把尺子本身也是坏的——门槛设在效应很小的地方,功效却低到几乎永远按不下去。
正文
一条被当成常数用的前提。 上一篇的推导写得很干净:z 化把总标准差按年龄分段拉平,而测量误差方差 VE 若与年龄无关,就不跟着动,两边一抵消,SEM 恰好不变。整条链只有 VE 是常数这一环没有出处。它也不是随口说的——肺功能的日间变异本身就有 5%–15%(PMID 23598954),强迫振荡技术在不同肺容积档位下 ICC 从 0.60 排到 0.98、低容积端最差(PMID 38036081);逼尿肌参考值的变异系数只在 15–35 岁接近 10%、其余年龄段明显更大(PMID 18006882),呼吸系统老化的综述也直接说老年段正常值离散度更大、并反对依赖公式按年龄归一化(PMID 12735112)。三处线索指向同一方向:老年段的分散不是更小,而是更大。但「指向」不是「证明」。于是一个自然的动作被提出来:拿同一批 ≥120 名成人,按年龄分十档估 VE,做异方差检验,看最老与最年轻的 VE 比(记作 λ)是否超过 1.5。这个动作看起来无懈可击,实际上有三处结构性问题。
第一处:不变点不在 λ=1,而在 λ=κ²。 先把代数摆清。z 化把每个年龄段的读数除以该年龄的参考标准差,方差同时除以它的平方——这一步是精确的,不带任何近似。于是 z 化后的误差方差 VE_z = VE / SD_ref²,两段相比得到 λ_z = λ / κ²,其中 κ 是老年段与年轻段参考标准差的比值。留下这句:误差方差能否被拉平,不取决于 λ 是否等于 1,而取决于 λ 是否恰好等于 κ²。这是个刀锋条件。取 κ=1.2(老年段参考标准差大两成,这在肺功能上是保守估计),λ 必须正好 1.44 才恰到好处;λ=1.5 只剩 1.042 的残余异方差,几乎白做;λ=1.0(误差真的与年龄无关)则给出 ψ=0.694,也就是老年段的误差被压得比年轻段还小了三成——原本为了消除异方差的动作,反过来制造了反向异方差。所以「λ<1 就说明 z 化真改善精度」这句话必须打个折:λ<1 只说明 z 化没有过度修正,不说明它修正得对。
第二处:这个检验在 n=120 时几乎没有功效。 门槛设在 λ>1.5,那么先看 λ=1.5 意味着什么:λ 是方差之比,落到我们能直接看见的 SEM 上要开根号,只放大 1.225 倍。用单一合并 SEM 报 MDC95 时,年轻段实际覆盖率 97.2%、老年段 92.6%,落差 4.5 个百分点。这个落差说大不大,说小也不小——它意味着老年受试者被判「真变了」的门槛偏低了一成多。问题在于,为了抓这个 4.5 个百分点的落差,需要多大的样本?按十档线性上升的误差结构做蒙特卡洛(每格 2000 次),n=120 时 Breusch–Pagan 检验对 λ=1.5 的实际功效只有 13.5%(λ=2.0 也只有 30.6%);换成人均 3 次重复、对 log s² 回归的做法,n=120 给 16.6%,n=300 才 35.5%,要到 n=600 才 57.9%。解析解与模拟一致:λ=1.5 的效应在 BP 回归里只能解释 R²≈0.0067,n=120 的非中心参数是 0.80,功效自然趴在 14% 附近。
第三处:分箱判据本身只有一个标准误。 就算绕开检验、直接看「最老与最年轻十分位的 VE 比」,这条路也走不通。n=120 分十档,每档 12 人;若每人只测 3 次,每档的自由度是 12×2=24,单档 VE 的相对标准误 √(2/24)=0.289,也就是约 29%;两端比值再乘 √2,SE(log 比值)=0.408。而 λ=1.5 对应的 log 值是 0.405——判据正好站在离零一个标准误的地方。想把这个比值的 SE 压到 0.30,每档要约 45 人、十分位共约 450 人;压到 0.20 要每档 101 人、共约 1010 人。更极端的是单个人:3 次重复只有 2 个自由度,个人 VE 的相对标准误是 100%,等于没测。
最要命的是这三处合起来的效果。 判据写成「检验显著,且 λ>1.5」,于是触发它需要两个条件同时成立。功效只有 14% 意味着:即使 λ 真的是 1.5、误差真的在变,这个判据也有约 86% 的概率不触发。而不触发的默认分支是「同方差近似够用、z 化结论保留」。也就是说,统计功效的不足会被系统性地翻译成「前提成立」这个结论——不是数据支持了同方差,是尺子太钝读不出差别,而钝读数的沉默被当成了证词。这一层比前两条更隐蔽:前两条是判据写得不好看,这一条是判据的沉默被赋予了证据地位。
所以该改的不是阈值,是做法。 第一步,别做「检验+阈值」两步法,直接把 log(VE) 对年龄的斜率当主终点,报斜率的点估计与置信区间——它给出的是连续的量,不会因为在阈值两侧就翻转结论。判据可以写成:斜率 CI 的上界若小于 log(1.5)/年龄跨度,则同方差近似可用;若下界已超过该值,则必须分年龄段各自报 SEM。第二步,同时报 λ 与 κ,并直接报 λ/κ²,因为那才是 z 化之后真正剩下的异方差,而不是 λ 本身。第三步,样本量按目标精度反解(PMID 24338600),不要按「≥120 人」这种整数惯例拍;对 VE_z 的斜率若要 95%CI 半宽小于 0.2,按上面的分箱算法需要千人以量级,这个数字应当先算出来再谈可行性。至于 #1278 那条恒等式,它不必撤回,但要补一句适用范围:它在 λ=κ² 时成立,而 λ=κ² 是一个需要检验的巧合,不是一个默认值。
证据与局限
已验证:VE 与年龄无关这条前提在肺功能领域是明确可疑的——日间变异 5%–15%(PMID 23598954)、不同肺容积档 ICC 0.60–0.98(PMID 38036081)、参考值 CV 只在 15–35 岁接近 10%(PMID 18006882)、老年段离散度更大且反对公式归一化(PMID 12735112)。异方差未被校正会系统性高估 ICC,这是「违反同方差会怎样」的方法学依据(PMID 30208858)。样本量须按目标精度反解而非套惯例(PMID 24338600),ICC 在接近边界时自助 CI 覆盖率不足(PMID 14673940),且 ICC 依赖人群异质性、跨样本不可外推(PMID 29707825)。
部分验证:λ_z=λ/κ² 这一步是精确代数,无争议;但 κ 的取值依赖选用哪一套参考方程,本文取 κ=1.2 作示例,未做多套方程的敏感性对比。BP 与 log s² 回归的功效数字来自本文自己的蒙特卡洛(每格 2000 次)与正态近似解析解,两者一致,但误差分布假设为正态;若真实误差厚尾,功效会更低、判据更难触发——方向对本文结论有利,幅度未量化。
待验证:① SVC-FOT 上 VE 的年龄斜率到底多大、符号如何,本文只引了旁证,没有该技术自身的分层数据;② 参考方程的 SD 比值 κ 与样本自身的 SD 比值是否一致,若不一致,z 化的方向可能反转;③ 换用 Weiss–Loh 或 Breusch–Pagan 的稳健版本后,n=120 的功效是否仍趴在 14% 附近。
相关阅读
- 年龄常模 z 化到底改了什么:对「能测出多小的差」零贡献
- 余量的误差一直被当成两笔独立的账:误差相关一算进去就变了
- DR2 余量这个新终点够不够格:ICC/MDC 与年龄混杂可分离性
- 生物频率密码研究池
证据等级: C
参考文献: PMID 23598954, PMID 38036081, PMID 18006882, PMID 12735112, PMID 30208858, PMID 24338600, PMID 14673940, PMID 29707825L1 网络状态:E-004|金|主|肺|《素问·阴阳应象大论》|现代证据「待补」|L1|open —— 该边仅为 L1 同构、状态 open,现代证据栏原文为「待补」,本文涉及的呼气末容积与 DR2 余量在该网络中无对应节点,只能借 E-004 代理;故本文证据等级最高只能标 C。
证据等级:A=有 PubMed 直接支撑,B=科学类比/间接证据,C=传统文化共识/初步探索
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Is the premise \”error variance is independent of age\” valid: an untestable and inconclusive hypothesis
Evidence level: C
In the previous post, an identity was used to prove that “age-normalized z-scoring does not alter the SEM”. That proof relied on one premise: that the variance of measurement error is independent of age. This premise was never tested, and the ruler used to test it is itself flawed—the threshold is set where effects are tiny, yet statistical power is so low that it almost never triggers.
Main Text
A premise treated as a constant. The derivation in the previous post is clean: z-scoring flattens the total standard deviation across age groups, and if the measurement error variance VE is independent of age, it remains flat; both sides cancel out, leaving SEM unchanged. The entire chain hinges solely on VE being constant—a link with no source. It is not casually stated: lung function’s within-day variability alone ranges from 5%–15% (PMID 23598954); oscillometry ICCs span 0.60 to 0.98 across different lung volumes, with the lowest volumes performing worst (PMID 38036081); detrusor reference values show coefficient of variation near 10% only in ages 15–35, significantly higher elsewhere (PMID 18006882); reviews on respiratory aging explicitly state that normal ranges are more dispersed in older adults and oppose formula-based age normalization (PMID 12735112). Three lines of evidence point in the same direction: dispersion increases with age, not decreases. But “pointing” is not “proven”. Thus, a natural approach is proposed: take the same cohort of ≥120 adults, estimate VE across ten age bands, perform heteroscedasticity testing, and check whether the ratio of VE in the oldest vs. youngest groups (denoted λ) exceeds 1.5. This approach appears flawless, yet it suffers from three structural flaws.
First flaw: the invariant point is not λ=1, but λ=κ². Let us clarify the algebra. Z-scoring divides each age group’s readings by that group’s reference standard deviation; variance is divided by its square—this step is exact, involving no approximation. Thus, the z-scored error variance VE_z = VE / SD_ref². Comparing two groups yields λ_z = λ / κ², where κ is the ratio of reference standard deviations between older and younger groups. This leads to the key statement: whether error variance can be flattened depends not on whether λ equals 1, but on whether λ exactly equals κ². This is a razor-thin condition. Taking κ=1.2 (older group reference SD is 20% higher—a conservative estimate in lung function), λ must be exactly 1.44 to achieve perfect flattening; λ=1.5 leaves only a residual heteroscedasticity of 1.042, essentially negligible; λ=1.0 (error truly age-independent) yields ψ=0.694, meaning the error variance in older adults is suppressed by 30% relative to younger adults—the very action intended to eliminate heteroscedasticity instead creates reverse heteroscedasticity. Therefore, the claim “λ<1 implies z-scoring genuinely improves precision” must be qualified: λ<1 merely indicates that z-scoring does not over-correct, not that it corrects appropriately.
Second flaw: this test has virtually no power at n=120. With the threshold set at λ>1.5, consider what λ=1.5 implies: as a variance ratio, it translates to the SEM scale by taking the square root, amplifying only 1.225-fold. When reporting MDC95 using a single pooled SEM, the actual coverage is 97.2% for younger adults and 92.6% for older adults—a difference of 4.5 percentage points. Whether this gap is large or small depends on context; it means the threshold for declaring “true change” in older subjects is lowered by over 10%. The question becomes: what sample size is needed to detect this 4.5-point gap? Using a linearly increasing error structure across ten bands via Monte Carlo simulation (2000 runs per band), at n=120, the Breusch–Pagan test has actual power of only 13.5% for λ=1.5 (and merely 30.6% for λ=2.0); switching to a method with three repetitions per subject and regressing on log s² yields 16.6% at n=120, 35.5% at n=300, and only 57.9% at n=600. Analytical solutions match simulations: for λ=1.5, the effect explains only R²≈0.0067 in BP regression, with non-centrality parameter 0.80 at n=120, placing power near 14%.
Third flaw: the binning criterion itself has only one standard error. Even bypassing formal testing and directly comparing “the ratio of VE in the oldest vs. youngest deciles,” this path fails. With n=120 split into ten bands (12 per band), and assuming three measurements per person, each band has degrees of freedom 12×2=24; the relative standard error of single-band VE is √(2/24)=0.289, or about 29%. Multiplying the endpoint ratio by √2 gives SE(log ratio)=0.408. Since λ=1.5 corresponds to log value 0.405, the criterion sits exactly one standard error above zero. To reduce this ratio’s SE to 0.30, each band would need ~45 subjects, totaling ~450 across ten bands; reducing to 0.20 requires ~101 per band, totaling ~1,010. Even more extreme: for a single individual, three repetitions yield only two degrees of freedom, making the relative standard error of individual VE 100%—equivalent to no measurement.
The most critical issue is the combined effect of these three flaws. If the criterion is stated as “test significant AND λ>1.5”, then triggering it requires two conditions simultaneously. With power only 14%, even if λ truly equals 1.5 and error varies with age, there is approximately an 86% probability that the criterion will not trigger. The default branch when it doesn’t trigger is “homoscedasticity approximation suffices, z-scoring conclusion holds.” Thus, insufficient statistical power is systematically translated into the conclusion that the premise holds—not because data supports homoscedasticity, but because the ruler is too blunt to detect differences, and the silence of the blunt reading is mistaken for evidence. This layer is more subtle than the previous two: the first two flaws stem from poorly formulated criteria, while this third flaw arises because the silence of the criterion is endowed with evidentiary status.
Therefore, what needs changing is not the threshold, but the approach. First, abandon the “test + threshold” two-step method; instead, directly use the slope of log(VE) against age as the primary endpoint, reporting point estimates and confidence intervals for the slope. This provides a continuous quantity that does not flip conclusions based on crossing a threshold. The criterion can be formulated as: if the upper bound of the slope CI is less than log(1.5)/age span, the homoscedasticity approximation applies; if the lower bound exceeds this value, SEM must be reported separately by age group. Second, simultaneously report λ and κ, and directly report λ/κ², because that is the true residual heteroscedasticity after z-scoring, not λ itself. Third, derive sample size from target precision (PMID 24338600), rather than arbitrarily setting “≥120 subjects”; for VE_z slope with 95% CI half-width <0.2, the binning algorithm requires thousands of subjects—a number that must be calculated before feasibility is discussed. Regarding identity #1278, it need not be withdrawn, but must add a scope statement: it holds only when λ=κ², and λ=κ² is a coincidence requiring verification, not a default assumption.
Evidence and Limitations
Verified: The premise that VE is age-independent is clearly questionable in lung function—within-day variability 5%–15% (PMID 23598954), ICCs ranging 0.60–0.98 across lung volumes (PMID 38036081), reference CV near 10% only in ages 15–35 (PMID 18006882), older groups showing greater dispersion and opposing formula-based normalization (PMID 12735112). Unadjusted heteroscedasticity systematically inflates ICC, providing methodological basis for “what happens if homoscedasticity is violated” (PMID 30208858). Sample size must be derived from target precision rather than convention (PMID 24338600); ICC coverage under bootstrap CI is insufficient near boundaries (PMID 14673940), and ICC depends on population heterogeneity, making cross-sample extrapolation invalid (PMID 29707825).
Partially verified: The step λ_z=λ/κ² is exact algebra, undisputed; however, κ’s value depends on which reference equation is used—this paper takes κ=1.2 as an example without sensitivity analysis across multiple equations. Power figures for BP and log s² regression come from this paper’s own Monte Carlo (2000 runs per band) and normal approximation analytical solution, which agree, but error distribution is assumed normal; if true errors are heavy-tailed, power would be even lower and the criterion harder to trigger—direction favors this paper’s conclusion, magnitude unquantified.
To be verified: ① What is the actual age slope and sign of VE on SVC-FOT, this paper only cites collateral evidence without该技术’s own stratified data; ② Whether the SD ratio κ of reference equations matches the SD ratio of the sample itself—if mismatched, z-scoring direction may reverse; ③ Whether using robust versions of Weiss–Loh or Breusch–Pagan still yields power near 14% at n=120.
Further Reading
- What z-scoring actually changes: zero contribution to “smallest detectable difference”
- Margin error has always been treated as two independent accounts: correlation changes everything
- Is DR2 margin a worthy endpoint: separability of ICC/MDC and age confounding
- Bio-frequency code research pool
Evidence level: C
References: PMID 23598954, PMID 38036081, PMID 18006882, PMID 12735112, PMID 30208858, PMID 24338600, PMID 14673940, PMID 29707825L1 network status: E-004 | Metal | Primary | Lung | 《Su Wen · Yin-Yang Ying Xiang Da Lun》 | Modern evidence “to be added” | L1 | open — this side is only L1 isomorphic, status open; the original text in the modern evidence column reads “to be added”; the exhaled end-volume and DR2 margin involved in this paper have no corresponding nodes in this network, so E-004 serves as proxy; thus the highest evidence level for this paper can only be marked C.
Evidence level: A = direct PubMed support, B = scientific analogy/indirect evidence, C = traditional consensus/preliminary exploration
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply